Project

A Multicenter Phase III Randomized study with second line chemotherapy plus or minus Bevacizumab in patients with Platinum sensitive Epithelial ovarian cancer recurrence after a Bevacizumab/chemotherapy first line. MITO-16b, MANGO-OV2b

Completed · 2020 until 2023

Weder Patrik, Harder Anja, Quinter Janine